Celltrion, Top Search Ranking... Stock Price -1.89%
As of 10:30 AM on the 21st, Celltrion is trading at 286,000 KRW, down 1.89% from the previous day. This represents a 10.06% decrease compared to September 8. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners are tentatively recorded as net buyers of 2,372 shares. Over the past five days, individual investors have net purchased 374,068 shares, while foreigners and institutions have net sold 211,077 shares and 187,634 shares, respectively.
On September 18, Celltrion became a market issue with the news of 'approval for Phase 2 and 3 clinical trials of a COVID-19 treatment,' leading to a rise in its stock price.
Hot Picks Today
Up to 600 Million Won for Semiconductors, 160 Million Won Bonus for Loss-Making Non-Memory… Samsung Electronics Labor and Management Reach Tentative Deal on Unprecedented Performance Compensation (Comprehensive)
- "Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- Opening a Bank Account in Korea Is Too Difficult..."It Costs 150,000 Won Just to Open a Child's Account or Check Card" [Foreigner K-Finance Status]②
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help": How Much Do Those Bowing 90 Degrees Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
